| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-06 |
| mRNA |
TPCA-1 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
4e-06 |
| mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
4e-06 |
| mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.23 |
4e-06 |
| mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
| mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-06 |
| mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
6e-06 |
| mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-06 |